Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 26Sarcoma 16Neoplasm Metastasis 12Carcinoma, Non-Small-Cell Lung 9Ovarian Neoplasms 8Breast Neoplasms 8Recurrence 6Neoplasms 5Melanoma 4Liposarcoma 4Leiomyosarcoma 4Glioblastoma 4Fallopian Tube Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Small Cell Lung Carcinoma 3Prostatic Neoplasms 3Neuroendocrine Tumors 3Lung Neoplasms 3Kidney Neoplasms 3Hemangiosarcoma 3Gastrointestinal Stromal Tumors 3Thyroid Neoplasms 2Thyroid Carcinoma, Anaplastic 2Sarcoma, Synovial 2Sarcoma, Alveolar Soft Part 2Rhabdomyosarcoma 2Pancreatic Neoplasms 2Osteosarcoma 2Gliosarcoma 2

Interventions

Gemcitabine 26Capecitabine 16Oxaliplatin 14Fluorouracil 13Cisplatin 12Leucovorin 9pembrolizumab 5Erlotinib Hydrochloride 5Bevacizumab 5durvalumab 4Trastuzumab 4Specimen Handling 4Sorafenib 4Magnetic Resonance Spectroscopy 4130-nm albumin-bound paclitaxel 4trifluridine tipiracil drug combination 3Lapatinib 3Irinotecan 3Carboplatin 3Biopsy 3tremelimumab 2toripalimab 2regorafenib 2lenvatinib 2dehydroftorafur 2cobimetinib 2atezolizumab 2anlotinib 2Nivolumab 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Gallbladder Neoplasms × pazopanib × Clear all
NCT01855724 2018-11-07

Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer

Hellenic Cooperative Oncology Group

Phase 2 Terminated
29 enrolled
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡